Seattle-area company that aims to treat disease with radio frequency energy files for IPO by Charlotte Schubert on August 17, 2022August 17, 2022 at 5:09 pm EMulate Therapeutics, a 20-year-old Bellevue, Wash.-based company developing radio frequency energy technology to treat a range of diseases, filed to go public Tuesday. The 7-person company, previously known as Nativis,… Read More